These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6822136)

  • 41. A mini-review of non-parenteral clonidine preparations for paediatric sedation.
    Hanning SM; Orlu Gul M; Toni I; Neubert A; Tuleu C;
    J Pharm Pharmacol; 2017 Apr; 69(4):398-405. PubMed ID: 28033670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clonidine as an adjuvant to prolong local analgesia in conventional scleral buckle surgery.
    Górniak M; Proost JH; Veckeneer M; Mulder VC; Wubbels RJ
    J Ocul Pharmacol Ther; 2014 Nov; 30(9):777-82. PubMed ID: 25188774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of long-term administration of clonidine on plasma renin activity.
    De Wurstemberger B; Gysling E
    Can Med Assoc J; 1976 Dec; 115(11):1107-8. PubMed ID: 1000443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacokinetics of clonidine.
    Lowenthal DT; Matzek KM; MacGregor TR
    Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal clonidine for the treatment of essential hypertension.
    McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC
    Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical trials with clonidine-chlorthalidone, a combined preparation in the treatment of hypertensive diseases].
    Dejaco RM; Hartl O
    Wien Med Wochenschr; 1973 Feb; 123(7):96-9. PubMed ID: 4631628
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of sustained-release and standard preparations of clonidine in essential hypertension.
    Fyhrquist F
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment with Pharmachim's Chlophazolin of hypertension and symptomatic hypertonia].
    Koĭchev A; Belovezhdov N; Chakŭrski I; Stefanov G; Angelova I
    Vutr Boles; 1986; 25(1):72-7. PubMed ID: 2872753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinically significant aspects of the pharmacodynamics of clofelin in hypertension].
    Moiseev VS; Ivleva AIa; Kobalava ZhD; Lepakhin VK
    Klin Med (Mosk); 1990 Aug; 68(8):46-52. PubMed ID: 2084370
    [No Abstract]   [Full Text] [Related]  

  • 50. A placebo-controlled study of three clonidine doses for smoking cessation.
    Gourlay S; Forbes A; Marriner T; Kutin J; McNeil J
    Clin Pharmacol Ther; 1994 Jan; 55(1):64-9. PubMed ID: 8299319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between clonidine kinetics and its blood pressure effects.
    Frisk-Holmberg M; Paalzow L
    Acta Med Scand Suppl; 1979; 625():68-73. PubMed ID: 285578
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and mild hypertension.
    Wallin JD; Krane NK; Bergman S; Morgan M
    J Clin Hypertens; 1985 Dec; 1(4):315-21. PubMed ID: 3836300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Possible involvement of atrial natriuretic factor and vasopressin in antihypertensive mechanism of clonidine in humans].
    He B; Chen DG
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):283-5. PubMed ID: 7901963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intranasal clonidine pharmacokinetics.
    Blackburn L; Almenrader N; Larsson P; Anderson BJ
    Paediatr Anaesth; 2014 Mar; 24(3):340-2. PubMed ID: 24467572
    [No Abstract]   [Full Text] [Related]  

  • 55. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clonidine.
    J Ir Med Assoc; 1973 Aug; 66(15):423-4. PubMed ID: 4727939
    [No Abstract]   [Full Text] [Related]  

  • 57. Efficacy and acceptability of different dosage schedules of clonidine.
    Jain AK; Ryan JR; Vargas R; McMahon FG
    Clin Pharmacol Ther; 1977 Apr; 21(4):382-7. PubMed ID: 849670
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK; Thomas GW; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1979 Nov; 2(9):499-500. PubMed ID: 522807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of clinic and home blood pressure levels and the role of the sympathetic nervous system in clinic-home differences.
    Saito I; Takeshita E; Hayashi S; Takenaka T; Murakami M; Saruta T; Nagano S; Sekihara T
    Am J Hypertens; 1990 Mar; 3(3):219-24. PubMed ID: 2322433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of clonidine during pregnancy and nursing.
    Hartikainen-Sorri AL; Heikkinen JE; Koivisto M
    Obstet Gynecol; 1987 Apr; 69(4):598-600. PubMed ID: 3822302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.